{"org_id": "03130236", "org_name_cn": "浙江华海药业股份有限公司", "org_short_name_cn": "华海药业", "org_name_en": "Zhe Jiang Hua Hai Pharmaceutical Co.,Ltd.", "org_short_name_en": "huahaipharm", "main_operation_business": "原料药及医药中间体的制造和销售。", "operating_scope": "　　许可经营项目：药品的生产(范围详见《中华人民共和国药品生产许可证》)；有机化学原料制造(凭《安全生产许可证》)。一般经营项目：医药中间体制造，经营进出口业务。(上述经营范围不含国家法律法规规定禁止，限制和许可经营的项目)。经政府有关部门批准并办理工商登记手续，公司可另开设业务发展所需的投资与经营项目，扩大经营范围。\r\n　　", "district_encode": "331082", "org_cn_introduction": "浙江华海药业股份有限公司是一家主要经营原料药、医药中间体、制剂的生产和销售的公司。公司的主要产品有普利类、沙坦类等高血压原料药。\r\n　　公司是国内首家通过美国FDA制剂认证的企业，在国际GMP认证、制剂以及原料药的海外注册、国际合作等领域处于国内同行业领先地位。", "legal_representative": "陈保华", "general_manager": "陈保华", "secretary": "祝永华", "established_date": 914860800000, "reg_asset": 1491754938.0, "staff_num": 6655, "telephone": "86-576-85991096", "postcode": "317024", "fax": "86-576-85016010", "email": "600521@huahaipharm.com", "org_website": "www.huahaipharm.com", "reg_address_cn": "浙江省台州市临海市汛桥", "reg_address_en": "", "office_address_cn": "浙江省台州市临海市汛桥", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1046707200000, "provincial_name": "浙江省", "actual_controller": "陈保华 (25.14%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "李宏", "executives_nums": 22, "actual_issue_vol": 35000000.0, "issue_price": 15.55, "actual_rc_net_amt": 526017625.0, "pe_after_issuing": 19.98, "online_success_rate_of_issue": null, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}